Articles From: Allegiant Travel Company Announces the Resignation of Andrew Levy President and Chief Operating Officer to ALLETE Board of Directors Declares Dividend on Common Stock


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022992-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/1/11G022992/convertedPNGlogo-1694551662.jpg LAS VEGAS, NV--(Marketwired - October 01, 2014) - Allegiant (NASDAQ: ALGT) announced today that Andrew C.
Sign-up for Allegiant Travel Company Announces the Resignation of Andrew Levy President and Chief Operating Officer investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G023112-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/2/11G023112/convertedPNGlogo-1676929179.jpg LAS VEGAS, NV--(Marketwired - October 02, 2014) - Allegiant Travel Company (NASDAQ: ALGT) has scheduled its third quarter 2014 financial results conference call for Wednesday, October 22nd at 4:30 p.m. Eastern.
Sign-up for Allegiant Travel Company Schedules Third Quarter 2014 Earnings Call investment picks
47th Consecutive Profitable Quarter LAS VEGAS, Oct.
Sign-up for Allegiant Travel Company Third Quarter 2014 Financial Results investment picks
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, announced today that it has completed the amendment and extension of its senior credit facility.
Sign-up for Allegion Completes Amendment and Extension of Existing Credit Facility investment picks
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, announced that its board of directors declared a quarterly dividend of $0.08 cents per ordinary share of the company.
Sign-up for Allegion Declares Quarterly Dividend investment picks
2014/10/13
School leaders face unprecedented security challenges that require them to stay current on the latest security technologies and protocols.
Sign-up for Allegion Offers Three Ways to Improve the Physical Security of Schools and Better Protect Students and Staff investment picks
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, today reported third quarter 2014 net revenues of $546.7 million, up 3.3 percent compared to the prior year, and net earnings of $62.4 million, or $0.64 per share from continuing operations.
Sign-up for Allegion Reports Third Quarter 2014 Financial Results; Increases Full-Year 2014 EPS Outlook investment picks
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, will release its 2014 third-quarter financial results on Thursday, October 30, 2014 before the market opens.
Sign-up for Allegion Schedules Conference Call and Webcast to Announce 2014 Third-Quarter Financial Results investment picks
Global Home and business security solutions provider Allegion plc (NYSE:ALLE) recently selected Xerox (NYSE:XRX) to support the company’s IT infrastructure as part of a five-year agreement.
Sign-up for Allegion Selects Xerox for Global IT Management and Delivery investment picks
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, is hosting two events to showcase the company’s recent innovations in its electronic security portfolio.
Sign-up for Allegion to Host Press Conference, School Security Seminar, at ASIS International 2014 investment picks
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions announced today that David D.
Sign-up for Allegion to Present at the 2014 Imperial Capital Security Investor Conference investment picks
Allergan, Inc., (NYSE: AGN) announced today that the U.S. Food and Drug Administration (FDA) has approved OZURDEX® (dexamethasone intravitreal implant) 0.7 mg, a sustained-release biodegradable steroid implant, for the treatment of diabetic macular edema (DME). OZURDEX® was originally approved in June as a treatment for DME in adult patients who have an artificial lens implant (pseudophakic) or who are scheduled for cataract surgery (phakic). Based on ongoing review of clinical data demonstrating efficacy and safety, the FDA has now approved OZURDEX® for use in the general DME patient population.
Sign-up for Allergan Announces FDA Approves Revised Indication for OZURDEX® (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema investment picks
Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jim Hindman, Executive Vice President, Finance and Business Development, Chief Financial Officer, discuss the Company’s third quarter 2014 results on Monday, October 27, 2014 beginning promptly at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time) before answering questions.
Sign-up for Allergan Announces Quarterly Conference Call investment picks
Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that its Board of Directors has approved amendments to the Company’s bylaws that streamline the process associated with calling a special meeting of stockholders.
Sign-up for Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws investment picks
The Board of Directors of Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued the following statement: Goldman, Sachs & Co.
Sign-up for Allergan Board of Directors Issues Statement investment picks
Allergan Inc. (AGN) said Monday it would consider an improved bid from Valeant Pharmaceuticals International Inc. (VRX) , although it repeated that Valeant's offers have so far been inadequate and have undervalued Allergan.
Sign-up for Allergan board skeptical of Valeant's offer to improve bid investment picks
Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today commented on the ruling in the United States District Court for the Central District of California in the Company’s federal securities litigation against Valeant Pharmaceuticals International, Inc. (“Valeant”), Pershing Square Capital Management, L.P. (“Pershing Square”) and its principal, William A.
Sign-up for Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square investment picks
Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued the following statement in response to Valeant Pharmaceuticals International, Inc.’s (“Valeant”) October 27, 2014 letter to the Allergan Board of Directors.
Sign-up for Allergan Comments on Valeant Letter investment picks
By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) -- While Valeant says that it handily beat analyst estimates for the third quarter, its current acquisition target, Botox maker Allergan Inc., offered its own take on the results.
Sign-up for Allergan files rebuttal to Valeant earnings investment picks
Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued a statement regarding recent correspondence between Allergan and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (“Valeant”) that was published by Valeant: Goldman, Sachs & Co.
Sign-up for Allergan Issues Statement Regarding Recent Valeant Correspondence investment picks
Allergan, Inc. (NYSE: AGN) today provided the following updates on earnings per share (EPS) and sales expectations based on current information.
Sign-up for Allergan Provides Update on Earnings Per Share and Sales Expectations investment picks
Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended September 30, 2014.
Sign-up for Allergan Reports Third Quarter 2014 Operating Results investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Allergan, Inc. (“Allergan”) (NYSE: AGN) concerning the acquisition by Actavis.
Sign-up for ALLERGAN SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis investment picks
Botox maker Allergan Inc. (AGN) and Irish pharmaceutical company Actavis PLC (ACT) are close to a friendly deal, which could be announced as early as Monday, the Wall Street Journal reported Sunday.
Sign-up for Allergan, Actavis near cash-and-stock deal: WSJ investment picks
2014/11/16
By Jonathan D.
Sign-up for Allergan, Actavis Near Deal -- 2nd Update investment picks
2014/11/16
By Jonathan D.
Sign-up for Allergan, Actavis Near Deal -- 3rd Update investment picks
2014/11/17
WILMINGTON, Del.
Sign-up for ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/11/21
Rigrodsky & Long, P.A.: Do you own shares of Allergan, Inc. (NYSE: AGN )? Did you purchase any of your shares prior to November 17, 2014?
Sign-up for ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
ALLETE, Inc. (NYSE:ALE) board of directors has declared a quarterly dividend of 49 cents per share of common stock.
Sign-up for ALLETE Board of Directors Declares Dividend on Common Stock investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Allegiant Travel Company Announces the Resignation of Andrew Levy President and Chief Operating Officer to ALLETE Board of Directors Declares Dividend on Common Stock
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent